These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 1762074)
1. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. VI. Effect of the calcium channel blocker nimodipine on zidovudine kinetics in monkeys. Gallo JM; Swagler AR; Mehta M; Qian M J Pharmacol Exp Ther; 1993 Jan; 264(1):315-20. PubMed ID: 8423534 [TBL] [Abstract][Full Text] [Related]
3. Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration. Melvin GC; Ellison SR; Monk CM; Bates TR Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):193-204. PubMed ID: 2277865 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys. Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160 [TBL] [Abstract][Full Text] [Related]
5. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats. Aiba T; Sakurai Y; Tsukada S; Koizumi T J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370 [TBL] [Abstract][Full Text] [Related]
6. Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis. Singlas E; Pioger JC; Taburet AM; Colin JN; Fillastre JP Clin Pharmacol Ther; 1989 Aug; 46(2):190-7. PubMed ID: 2758728 [TBL] [Abstract][Full Text] [Related]
7. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers. Hedaya MA; Elmquist WF; Sawchuk RJ Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917 [TBL] [Abstract][Full Text] [Related]
8. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Cretton EM; Xie MY; Bevan RJ; Goudgaon NM; Schinazi RF; Sommadossi JP Mol Pharmacol; 1991 Feb; 39(2):258-66. PubMed ID: 1996084 [TBL] [Abstract][Full Text] [Related]
9. Influence of hemodialysis on zidovudine (AZT) and its glucuronide (GAZT) pharmacokinetics: two case reports. Garraffo R; Cassuto-Viguier E; Barillon J; Chanalet L; Lapalus P; Duplay H Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):535-9. PubMed ID: 2613387 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of drug interactions with zidovudine. I: Probenecid and zidovudine in monkeys. Qian MX; Finco TS; Mehta M; Viswanathan CT; Gallo JM J Pharm Sci; 1991 Nov; 80(11):1007-11. PubMed ID: 1815049 [TBL] [Abstract][Full Text] [Related]
11. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit. Hedaya MA; Sawchuk RJ J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262 [TBL] [Abstract][Full Text] [Related]
12. Modulation of 3'-azido-3'-deoxythymidine catabolism by probenecid and acetaminophen in freshly isolated rat hepatocytes. Cretton EM; Sommadossi JP Biochem Pharmacol; 1991 Sep; 42(7):1475-80. PubMed ID: 1930271 [TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat. Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177 [TBL] [Abstract][Full Text] [Related]
14. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. de Miranda P; Good SS; Yarchoan R; Thomas RV; Blum MR; Myers CE; Broder S Clin Pharmacol Ther; 1989 Nov; 46(5):494-500. PubMed ID: 2582706 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys. Gallo JM; Finco TS; Swagler AR; Mehta MU; Viswanathan CT; Qian M AIDS Res Hum Retroviruses; 1992 Feb; 8(2):277-83. PubMed ID: 1540413 [TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of [3H]-l-menthol in the rat. Yamaguchi T; Caldwell J; Farmer PB Drug Metab Dispos; 1994; 22(4):616-24. PubMed ID: 7956738 [TBL] [Abstract][Full Text] [Related]
17. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile. Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254 [TBL] [Abstract][Full Text] [Related]
18. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys. Colletti AE; Krieter PA Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572 [TBL] [Abstract][Full Text] [Related]
20. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]